Theravance Biopharma Aktie
8,45
EUR
+0,20
EUR
+2,42
%
9,73
USD
+0,20
USD
+2,10
%
Werbung
Theravance Biopharma Aktie Analyse
16.06.17 | Theravance Biopharma Overweight | Cantor Fitzgerald | |
11.05.17 | Theravance Biopharma Buy | Needham & Company, LLC | |
21.12.16 | Theravance Biopharma Buy | Needham & Company, LLC | |
12.10.16 | Theravance Biopharma Underperform | Robert W. Baird & Co. Incorporated | |
03.02.15 | Theravance Biopharma Neutral | Robert W. Baird & Co. Incorporated |
Werbung
Werbung